Chronic myelogenous leukemia is a myeloproliferative disorder. It is characterized by a
biphasic or triphasic clinical course in which a benign chronic phase is followed by …

Chronic myelogenous leukemia (CML) is a myeloproliferative disorder that follows a
characteristic clinical course in which a chronic phase of variable duration precedes an …

Chronic myelogenous leukemia (CML) is a clonal hematopoietic stem cell disorder
characterized by a specific chromosomal translocation, t (9; 22), that results in a shortened …

With an annual incidence of about ten in 1,000,000 people, chronic myeloid leukemia (CML)
accounts for most cases of myeloproliferative disease and for 20% of all leukemias. While …

Chronic myeloid leukemia (CML) is a clonal myeloproliferative expansion of transformed,
primitive hematopoietic progenitor cells. It involves myeloid, monocytic, erythroid …

Chronic Myeloid Leukaemia (CML) is a clonal, myeloproliferative disease that develops
when a single, pluripotential, haemopoetic stem cell acquires the Philadelphia chromosome …

Chronic myelogenous leukemia classically progresses through 3 phases, becoming more
resistant to treatment in each successive phase. The majority of patients present in the …

With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two
pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the …

Chronic myelogenous leukemia represents 7–20% of all leukemia cases, with a worldwide
incidence projected at less than one to two per 100,000 people. Approximately 85% of …

In the last decade, improvements in both non-transplant and transplant therapy have
extended the lives of patients with CML, particularly those in chronic phase. The future will …